Keywords: over, patients, enrolled, generex, oral-lyn, trial, usa-based

Over 200 patients enrolled in Generex' Oral-Lyn trial

Article | 22 September 2008

Print This

USA-based Generex Biotechnology has reached an enrollment milestone in its pivotal Phase III study of Oral-Lyn prandial oral insulin spray.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in